![](https://www.biopharmadive.com/imgproxy/7pB8MlVPAaQhyRvpELTFeOQa4Rx7pz4FziO31fU8Gu8/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL01DUF8wMjk2LmpwZw==.webp)
Recursion to absorb Exscientia in ‘techbio’ deal
Dive Brief: Recursion and Exscientia, two artificial intelligence firms, on Thursday announced that they would combine, betting their complementary skills in technology-based drug discovery will lead to faster and better development of medicines. The new …